
Welcome to
Australian Fragility Fracture Foundation
The Australian Fragility Fracture Foundation (AFFF) is a non-profit organization that aims to improve the care and outcomes of individuals with fragility fractures in Australia. A fragility fracture is a type of bone fracture that occurs from a minor fall or trauma, often in older people with weakened bones. These fractures can have serious consequences, including loss of mobility, independence, and quality of life.
The AFFF works to raise awareness of fragility fractures and the importance of prevention, early diagnosis, and timely treatment. We also support research and education to advance the understanding and management of fragility fractures in Australia. Our vision is to reduce the burden of fragility fractures and improve the lives of those affected by them.
The Australian component of the Australian & New Zealand Fragility Fracture Registry (ANZFFR) is a project of the AFFF, which will be referred to as the Australian Fragility Fracture Registry. The Australian Fragility Fracture Registry was initially supported by an unrestricted grant from Amgen Australia.
To date, we have completed a facility level survey of secondary fracture facilities in Australia, locked in the minimum data set for the patient-level registry, received ethics approval to collect patient specific data and started collecting patient data at Concord Hospital.

More Information
For more information on the registry, process and getting involved, please emailĀ [email protected]
2025 Annual Report - Available Now
We are delighted to share the second Australian and New Zealand Fragility Fracture Registry 2025 Annual Report.
This report contains data for over 15,000 people recruited to the Registry in New Zealand between 1st July 2023 and 30th June 2024 with 16-week follow up of participants to 31st October 2024.
Also, for the first time, we areĀ reporting on 52 week follow ups of people recruited the year before.
Fragility Fracture Patient Registry
The National Fragility Fracture Registry will collect patient specific data and has been developed in anticipation of ethics approval. There is a demo site available for testing.